MTOR and central nervous system cancer: In a similar study, NVP-BEZ235, an inhibitor of the PI3K/mTOR pathway, was shown to induce autophagy in glioma LN229, U87, U373 and SF763 cells in vitro and enhanced survival in glioma xenograft models [135].